GHRP-2 (10 mg Vial) Dosage Protocol

Research guide for gradual escalation dosing and reconstitution procedures for GHRP-2, a synthetic hexapeptide investigated for growth hormone release stimulation.

Quickstart Highlights

GHRP-2, or pralmorelin, functions as a synthetic hexapeptide that stimulates the ghrelin/GHS receptor on pituitary somatotroph cells to trigger growth hormone release. Operating independently of the typical GH-releasing hormone pathway makes it valuable for research into body composition and recovery support.

  • Reconstitute: Add 3.0 mL bacteriostatic water → concentration for daily dosing
  • Weekly dosing schedule: 100 mcg → 150 mcg → 200 mcg → 250-300 mcg over 12 weeks
  • Easy measuring: Standard U-100 insulin syringe measurement
  • Storage: Lyophilized: −20 °C (−4 °F), dry conditions; Reconstituted: 2–8 °C, use within 28 days

Dosing & Reconstitution Guide

Standard Once-Daily Approach (3mL reconstitution)

Daily Subcutaneous Protocol (3 mL reconstitution)

Duration Daily Dose Syringe Units Volume
Weeks 1–2 100 mcg 3 units 0.03 mL
Weeks 3–4 150 mcg 4.5 units 0.045 mL
Weeks 5–8 200 mcg 6 units 0.06 mL
Weeks 9–12 250–300 mcg 7.5–9 units 0.075–0.09 mL

Administration: Single daily subcutaneous injection at bedtime on an empty stomach (2–3 hours after eating).

Reconstitution Steps

  1. Draw 3.0 mL bacteriostatic water with sterile syringe
  2. Inject slowly along vial wall; avoid foaming
  3. Gently swirl/roll until dissolved (do not shake)
  4. Label with date; refrigerate at 2–8 °C, use within 28 days

Result: Standard reconstitution concentration for daily administration

Storage Guidelines

Key Administration Notes

⚠️ Research & Educational Purposes Only

This information is provided for research and educational purposes only. Peptides discussed are intended for laboratory research use only and are not approved for human consumption. Always consult qualified healthcare professionals for medical advice. Individual results may vary. This is not medical advice.